Riskpilot← Back to searchSign inGet full accessROA APOTEK AS
ASActiveOrg 919649259Hadelandsvegen 2128, 2740 RoaRetail sale of pharmaceutical products · NACE 4773Est. 20170 employees
Revenue 2021
NOK 16,5M
+20% vs 2020
EBITDA margin
4.3%
-22% vs 2020
Equity ratio
33.8%
Financial strength
Net profit 2021
NOK 328K
-28% vs 2020
| Revenue | NOK 16,5M | +20% |
| EBITDA | NOK 716K | -22% |
| Net profit | NOK 328K | -28% |
| Total assets | NOK 4,3M | +22% |
| Equity | NOK 1,4M | +29% |
| Employees | 0 | — |
Legal name
ROA APOTEK AS
Org number
919649259
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
2. oktober 2017
Share capital
NOK 3 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Company purpose
Salg av apotekvarer.
Address
Hadelandsvegen 2128, 2740 Roa
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 1 500 | 10 327 | 13 815 | 16 542 |
| Staff expenses | −0 | −32 | −2 209 | −2 773 | −3 232 |
| EBITDA | −65 | 188 | 361 | 912 | 716 |
| Depreciation & amort. | −0 | −51 | −305 | −305 | −282 |
| EBIT | −65 | 138 | 57 | 607 | 434 |
| Net financials | 0 | −6 | −39 | −26 | −13 |
| Profit before tax | −65 | 131 | 18 | 581 | 420 |
| Tax | −0 | 13 | 5 | 129 | 93 |
| Net profit | −65 | 118 | 14 | 453 | 328 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 533 | 3 106 | 2 906 | 3 506 | 4 260 |
| Equity | 530 | 648 | 661 | 1 114 | 1 442 |
| Long-term debt | 0 | 13 | 18 | 1 | 0 |
| Short-term debt | 3 | 2 445 | 2 227 | 2 391 | 2 818 |
| Total debt | 3 | 2 458 | 2 245 | 2 392 | 2 818 |
EBITDA margin
4.3%
This company
15.8%
Market median
-73% vs market
20172021
Equity ratio
33.8%
This company
38.2%
Market median
+12% vs market
20172021
Return on equity
22.7%
This company
18.4%
Market median
+23% vs market
20172021
Net profit margin
2.0%
This company
8.1%
Market median
-75% vs market
20172021
Asset turnover
3.88×
This company
1.12×
Market median
+246% vs market
20172021
Debt / equity
1.96×
This company
0.62×
Market median
-216% vs market
20172021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-09-19 – 2017-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
HF Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
HT Chief Executive Officer | Chief Executive Officer | 2017 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (1) | ||
| Deputy Chairman | 2017 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mckesson Norway Holding As
ROA APOTEK AS Board members of ROA APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helge Fauskrud | Chief Executive Officer | 0 companies |
| Helge Thorsen | Chief Executive Officer | 0 companies |
| Vegard Hoff | Board of Directors | 0 companies |
| Michael Roland Ecker | Chairman | 0 companies |
| Hamid Mahmood | Deputy Chairman | 0 companies |